Neuroprotective Effects of Empagliflozin Against Methamphetamine-Induced Withdrawal Syndrome in Mice: Involvement of Bdnf, Tlr4, and JNK Signaling Pathways and Oxidative Stress Biomarkers. (PubMed, Iran J Pharm Res) - Sep 10, 2026 - "The results of this animal study support empagliflozin as a potential treatment for neuropsychiatric dysfunction associated with METH withdrawal. Further clinical studies are needed to confirm the effects of empagliflozin."
IO biomarker • Journal • Preclinical • Alzheimer's Disease • CNS Disorders • Cognitive Disorders • Depression • Inflammation • Mood Disorders • Psychiatry • BDNF • MAPK8 • TLR4
|
|
Ali Kalantari Hesari; Alireza Lashgari; Hamed Ghavimi; Keivan Nedaei; Maede Hasanzadeh; Mina Ebrahimi; Mir-Jamal Hosseini
|